Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,470 public trials 2,851 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)

NCT04944979

Conditions
Agammaglobulinemia, Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Benioff Children's Hospital - Mission Bay San Francisco, California, United States
  • IMMUNOe Health and Research Centers Centennial, Colorado, United States
  • Johns Hopkins All Children's Hospital St. Petersburg, Florida, United States
  • Velocity Clinical Research - MedPharmics - Lafayette Lafayette, Louisiana, United States
View all 21 locations
View Trial Details
Active, not recruiting

Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

NCT06092879

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Angers, France
  • Novartis Investigative Site Limoges, Haute Vienne, France
  • Novartis Investigative Site Saint Priest Jarez, Pays de la Loire Region, France
  • Novartis Investigative Site Aix-en-Provence, France
View all 52 locations
View Trial Details
Active, not recruiting

Chronic Pain and Hemophilia

NCT05202951

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Chronic Pain, +12 more
Locations
  • CHU de Bordeaux Bordeaux, France
  • Centre Hospitalier Universitaire de Caen Normandie Caen, France
  • CH Métropole Savoie Chambéry, France
  • CHU de Clermont-Ferrand Clermont-Ferrand, France
View Trial Details
Active, not recruiting

Low GI Diet in Children and Adolescents With ALL

NCT03157323

Conditions
Acute Lymphoblastic Leukemia, Pediatric, Body Weight, Hematologic Diseases, +19 more
Locations
  • Connecticut Children's Medical Center Hartford, Connecticut, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Columbia University New York, United States
View Trial Details
Active, not recruiting

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML

NCT02091245

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia (CML) in Blast Crisis, +26 more
Locations
  • UCSF San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

A Study of Daratumumab in Patients With Newly Diagnosed Multiple Myeloma

NCT03290950

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Active, not recruiting

Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia

NCT00843882

Conditions
Anemia, Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Women's Cancer Care Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
View all 508 locations
View Trial Details
Active, not recruiting

Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial

NCT02275533

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
View all 46 locations
View Trial Details

Related conditions